Ho C H, Hou M C, Lin H C, Lee S D, Liu S M
Division of Hematology, Veterans General Hospital-Taipei, Taiwan, ROC.
Zhonghua Yi Xue Za Zhi (Taipei). 1998 Jun;61(6):332-8.
Laboratory diagnosis of disseminated intravascular coagulation (DIC) is difficult in patients with cirrhosis of the liver due to the complicated hemostatic changes of DIC. More recently, newer molecular hemostatic markers have been used to improve the diagnosis of DIC. This study evaluated the ability of the more advanced hemostatic tests to diagnose DIC in patients with cirrhosis of the liver.
A series of hemostatic tests and parameters including activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT), factor VIII assay, antithrombin (AT) activity, fibrinogen, plasminogen, protamine sulfate test (PST), fibrin (ogen) degradation product (FDP), D-dimer, thrombin-antithrombin complex (TAT) (measured by modified antithrombin, ATM), euglobulin lysis test (ELT) and platelet count were performed in 51 patients with cirrhosis of the liver. A diagnosis of DIC was made according to the following parameters and criteria: a) platelets less than 80 x 10(9)/l; b) PT greater than 1.5, c) APTT greater than 1.3; d) TT greater than 24 sec; e) AT less than 60%; f) ATM greater than 14.7 ng/ml (normal, mean +/- 3 SD); g) fibrinogen less than 1.50 g/l; h) positive PST; i) D-dimer greater than 1.0 microgram/ml; j) FDP greater than 20 micrograms/ml; k) ELT less than 150 min; l) plasminogen less than 50%. DIC was diagnosed if six or more of the above items were present, and at least two of them were item (a) to (h), and at least two were item (g) to (l).
Although eight patients had results that fitted the diagnostic criteria of DIC by using the more advanced tests, only two of them were diagnosed with DIC by conventional testing. The concentration of factor VIII in these eight patients did not markedly decrease.
New tests are not necessary to improve the diagnosis of DIC in patients with cirrhosis of the liver.
由于弥散性血管内凝血(DIC)的止血变化复杂,肝硬化患者的DIC实验室诊断存在困难。最近,更新的分子止血标志物已被用于改善DIC的诊断。本研究评估了更先进的止血检测方法对肝硬化患者DIC的诊断能力。
对51例肝硬化患者进行了一系列止血检测和参数测定,包括活化部分凝血活酶时间(APTT)、凝血酶原时间(PT)、凝血酶时间(TT)、因子VIII测定、抗凝血酶(AT)活性、纤维蛋白原、纤溶酶原、硫酸鱼精蛋白试验(PST)、纤维蛋白(原)降解产物(FDP)、D - 二聚体、凝血酶 - 抗凝血酶复合物(TAT)(通过改良抗凝血酶ATM测定)、优球蛋白溶解试验(ELT)和血小板计数。根据以下参数和标准诊断DIC:a)血小板低于80×10⁹/L;b)PT大于1.5;c)APTT大于1.3;d)TT大于24秒;e)AT低于60%;f)ATM大于14.7 ng/ml(正常,均值±3标准差);g)纤维蛋白原低于1.50 g/L;h)PST阳性;i)D - 二聚体大于1.0微克/ml;j)FDP大于20微克/ml;k)ELT低于150分钟;l)纤溶酶原低于50%。如果存在上述六项或更多项,且其中至少两项为(a)至(h)项,至少两项为(g)至(l)项,则诊断为DIC。
尽管使用更先进的检测方法时有八名患者的结果符合DIC诊断标准,但通过传统检测仅诊断出其中两名患者患有DIC。这八名患者的因子VIII浓度没有明显降低。
对于肝硬化患者,无需采用新的检测方法来改善DIC的诊断。